Slingshot Insights | Axsm Overview

AXSM Overview

Upcoming Projects (AXSM)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (AXSM)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (AXSM)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (AXSM)

FDA points to deficiencies within Axsome's (AXSM) AXS-05 regulatory application. Final decision on AXS-05's regulatory review for Major Depressive Disorder postponed for Aug. 22, 2021
Ticker: AXSM
Occurred on: Aug 23, 2021
Axsome Therapeutics (AXSM) Presents New Data from MOMENTUM Phase 3 Trial with AXS-07 in the Acute Treatment of Migraine
Ticker: AXSM
Occurred on: Sep 24, 2020
Axsome's (AXSM) AXS-05 Data Results from GEMINI Phase 3 Trial in Major Depressive Disorder
Ticker: AXSM
Occurred on: Dec 16, 2019
Phase 3 trial of AXS-02 for Complex regional pain syndrome (CRPS) expected to be completed by end of 2017 - Discontinued
Ticker: AXSM
Occurred on: Jan 09, 2018
AXS-02 Independent Data Monitoring Committee Recommends Continuation of COAST-1 Trial and Discontinuation of CREATE-1 Trial
Ticker: AXSM
Occurred on: Jan 09, 2018
Axsome Therapeutics Initiates Phase 3 Study of AXS-05 for Treatment Resistant Depression
Ticker: AXSM
Occurred on: Mar 17, 2016
Axsome Therapeutics Receives New U.S. Patent Covering AXS-02 for the Treatment of Complex Regional Pain Syndrome; Provides Patent Protection for AXS-02 into 2033 and Covers Uses of Oral Zoledronic Acid for Complex Regional Pain Syndrome
Ticker: AXSM
Occurred on: Mar 15, 2016
Axsome Therapeutics Announces Issuance of U.S. Patent Covering AXS-02 for the Treatment of Bone Marrow Lesions of the Knee; Provides Patent Protection into 2033
Ticker: AXSM
Occurred on: Jan 27, 2016

Strategic Initiatives (AXSM)

Don’t see a strategic initiative related to the company you care about? Create your own!